G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptid
G2E3
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle G2E3 Produkte
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- IWQRGKEEEG VYGFLIEDIR KEVNRASKLK CCVCKKNGAS IGCVAPRCKR
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA1333 antibody,
Alternative Names: KIAA1333 control peptide, KIAA1333 antibody Blocking Peptide, Anti-KIAA1333 Blocking Peptide, Kiaa1333 Blocking Peptide, FLJ20333 Blocking Peptide, G2E3 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
- Hintergrund
- KIAA1333 is a probable E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.
- Molekulargewicht
- 80 kDa
-
Sie sind hier:
